Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 4/20 | 0.47 |
| ▸ | QPCT | Q16769 | 2/20 | 0.45 |
| ▸ | MAOB | P27338 | 5/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | CETP | P11597 | 3/20 | 0.40 |
| ▸ | NOS1 | P29475 | 1/20 | 0.39 |
| ▸ | NOS2 | P35228 | 1/20 | 0.39 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.38 |
| ▸ | CAMKK2 | Q96RR4 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30245361 | 0.99 | APP (0.48) | APPQPCTMAOBALDH1A1CETP | |
| SCHEMBL30245241 | 0.97 | ALDH1A1 (0.46) | APPQPCTMAOBALDH1A1CETP | |
| SCHEMBL30245285 | 0.93 | QPCT (0.47) | APPQPCTMAOBALDH1A1CETP | |
| SCHEMBL25297747 | 0.93 | QPCT (0.47) | APPQPCTMAOBALDH1A1CETP | |
| SCHEMBL30245736 | 0.93 | QPCT (0.47) | APPQPCTMAOBALDH1A1CETP | |
| SCHEMBL30245848 | 0.93 | QPCT (0.46) | APPQPCTMAOBCETPCALM1 | |
| SCHEMBL30245313 | 0.93 | CETP (0.46) | APPQPCTMAOBALDH1A1CETP | |
| SCHEMBL25424604 | 0.93 | CETP (0.46) | APPQPCTMAOBALDH1A1CETP | |
| SCHEMBL30245702 | 0.92 | QPCT (0.45) | APPQPCTMAOBCETPCALM1 | |
| SCHEMBL30245259 | 0.92 | APP (0.44) | APPQPCTMAOBALDH1A1CETP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4384516-A1 | AMINOARYL-INTEGRIN AGONISTS COMPOUNDS | Texas Heart Institute (US) | 2024-06-19 | — | — | EP | claimed |
| WO-2023018472-A9 | AMINOARYL-INTEGRIN AGONISTS COMPOUNDS | TEXAS HEART INSTITUTE (US) | 2023-07-13 | — | — | WO | claimed |
| WO-2023018472-A1 | AMINOARYL-INTEGRIN AGONISTS COMPOUNDS | TEXAS HEART INSTITUTE (US) | 2023-02-16 | — | — | WO | claimed |
| EP-4384516-A1 | AMINOARYL-INTEGRIN AGONISTS COMPOUNDS | Texas Heart Institute (US) | 2024-06-19 | — | — | EP | disclosed |
| WO-2023018472-A9 | AMINOARYL-INTEGRIN AGONISTS COMPOUNDS | TEXAS HEART INSTITUTE (US) | 2023-07-13 | — | — | WO | disclosed |
| WO-2023018472-A1 | AMINOARYL-INTEGRIN AGONISTS COMPOUNDS | TEXAS HEART INSTITUTE (US) | 2023-02-16 | — | — | WO | disclosed |